Outcomes after recurrence of oral cancer vary by timing, site

	Tweet

Patients who have recurrence of oral squamous cell carcinoma tend to do worse if the new cancer appears at the same site early or if it appears in the lymph nodes six months or longer after initial treatment, according to a report in the December issue of Archives of Otolaryngology–Head & Neck Surgery, one of the JAMA/Archives journals.

Treating recurrences of oral squamous cell carcinoma (cancer in the thin, flat cells that line the lips and mouth) involves balancing the risk of complications against the potential benefit to the patient in terms of survival or controlling disease, according to background information in the article. “Currently, there is a paucity of published data to guide health care professionals regarding which clinicopathologic factors can be used to predict survival once the patient has developed recurrent disease,” the authors write.

Michael D. Kernohan, F.D.S.R.C.S., F.R.C.S., M.Sc., and colleagues at Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia, studied 77 patients who underwent salvage surgery (a procedure to remove cancer following an initial failed treatment) for disease that had recurred after treatment with surgery, radiation or a combination of the two. The median (midpoint) time to recurrence in these patients was 7.5 months, with 86 percent of recurrences occurring within 24 months. Thirty-nine experienced recurrence at the same site as their initial cancer; among the others, 27 had a recurrence in the neck on the same side as their initial cancer and 11 in the neck on the opposite side.

Overall, the five-year cancer survival rate among patients undergoing salvage surgery was 50 percent. Patients who were initially treated with combined therapy were 1.3 times as likely to die. “Presumably, the poor outcome reflects a combination of more advanced disease at initial presentation, resistant tumor biology and limited salvage options,” the authors write. “These findings suggest that patients whose disease fails maximal combination therapy have a low likelihood of successful salvage; we recommend that such patients be counseled accordingly.”

When the researchers assessed the relationship between survival and recurrence site, they found the association depended on the time to recurrence. Patients with locally recurring cancer (at the same site) tended to do worse if their disease had returned within six months, whereas those with regionally recurring cancer (at a different site) did worse if their cancer came back six months or longer after first treatment.

“Deciding which patients should undergo salvage surgery can be challenging and is often based on personal experience without the support of reliable evidence,” the authors conclude. “This retrospective study provides new information regarding survival prediction for these patients and demonstrates the interaction of clinically relevant prognostic factors that reflect variation in disease biology and behavior.”

###

(Arch Otolaryngol Head Neck Surg. 2010;136[12]:1235-1239. Available pre-embargo to the media at http://www.jamamedia.org.)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

To contact Michael D. Kernohan, F.D.S.R.C.S., F.R.C.S., M.Sc., e-mail .

For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail .

###

Contact: Michael D. Kernohan, F.D.S.R.C.S., F.R.C.S., M.Sc.

JAMA and Archives Journals

RELATED STORIES:
New ‘dentist’ test to detect oral cancer will save lives   Smoking increases risk for root canal treatment   Does Green Tea Prevent Cancer? Evidence Continues to Brew, But Questions Remain   New Method of Jaw Reconstruction for Oral Cancer Patients   Blue light used to harden tooth fillings stunts tumor growth   Ten Minutes That Could Save Your Life   Metformin May Lower Risk for Oral Cancer Development   5 Ways to Spot and Stop Smoking-Related Cancers   HPV-Positive Tumor Status Indicates Better Survival in Patients with Oropharyngeal Cancer   Oral Cancer Screenings at Dental Checkups Are Cost-Effective   Handheld device helps spot oral cancer   Avocados May Help Prevent Oral Cancer   Saliva proteins could help detection of oral cancer   MicroRNA in human saliva may help diagnose oral cancer   Gene may hold key to reducing spread of oral cancers   Oropharyngeal cancer patients experience post-surgery sleep apnea   Unique Surgery Creates Fully Usable Tongue   Oral cancer deaths declining among well-educated   Green Tea Shows Promise as Chemoprevention Agent for Oral Cancer   SIBLING proteins may predict oral cancer   Saliva RNA test for oral cancer   New approaches to the diagnosis of oral cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]